LRMR Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction ADC Therapeutics Q1 2026 Earnings EPS Beat but No Revenue Reported Stock Slips VTRS Q1 2026 Earnings Strong EPS Beat of 1517 Surprise Amid Stable Execution BLLN Q1 2026 Earnings Massive EPS Beat Drives Investor Caution Symbotic Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Growth Optimism KW Q1 2026 Earnings EPS Surprise of 1647 Highlights Cost Discipline Amidst Flat Revenue